Which has the lower trailing P/E, ASTH or BLFS?

BLFS has the lower trailing P/E: ASTH trades at 45.03 and BLFS at 37.72. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ASTH or BLFS?

Over the past five years, ASTH grew revenue faster — ASTH at a 53.77% CAGR versus BLFS at 6.78%.

Is ASTH or BLFS more profitable?

BLFS runs the higher net margin — ASTH at 1.05% versus BLFS at 49.06%.

How have ASTH and BLFS total returns compared?

Over the past 10 years, ASTH delivered 25.17% and BLFS delivered 36.27% annualized total return. Past performance doesn't predict future results.

Astrana Health, Inc. (ASTH) vs BioLife Solutions, Inc. (BLFS)

A side-by-side comparison of Astrana Health, Inc. and BioLife Solutions, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ASTH

Astrana Health, Inc.

$1.83B

$36.81HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

BLFS

BioLife Solutions, Inc.

$1.89B

$38.61HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ASTH vs BLFS

growth of $100 · dividends reinvested · last 10y

ASTH +820.3% (+24.9%/yr)BLFS +2119.0% (+36.3%/yr)BLFS compounded faster over this window

ASTH BLFS

ASTH vs BLFS: by the numbers

•BLFS is the larger company ($1.89B vs $1.83B market cap).
•BLFS trades at the lower trailing earnings multiple (37.72 vs 45.03 P/E), one valuation lens rather than an overall verdict.
•BLFS converts more revenue to profit (49.06% vs 1.05% net margin).
•ASTH grew revenue faster over the past five years (53.77% vs 6.78% CAGR).

Metrics side by side

Valuation

Metric	ASTH	BLFS
P/E ratio	45.03	37.72
Forward P/E	26.33	64.35
P/S ratio	0.47	18.35
P/B ratio	2.20	4.49
EV / EBITDA	13.43	170.26
FCF yield	8.68%	N/A

Profitability

Metric	ASTH	BLFS
Gross margin	9.22%	64.48%
Operating margin	2.61%	-1.12%
Net margin	1.05%	49.06%
ROE	4.88%	12.01%
ROIC	4.13%	1.72%

Growth (annualized)

Metric	ASTH	BLFS
Revenue CAGR (5Y)	53.77%	6.78%
EPS CAGR (5Y)	-15.06%	N/A
FCF CAGR (5Y)	18.35%	N/A
Total return CAGR (5Y)	-16.52%	-0.77%

Frequently asked

Which has the lower trailing P/E, ASTH or BLFS?: BLFS has the lower trailing P/E: ASTH trades at 45.03 and BLFS at 37.72. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ASTH or BLFS?: Over the past five years, ASTH grew revenue faster — ASTH at a 53.77% CAGR versus BLFS at 6.78%.
Is ASTH or BLFS more profitable?: BLFS runs the higher net margin — ASTH at 1.05% versus BLFS at 49.06%.
How have ASTH and BLFS total returns compared?: Over the past 10 years, ASTH delivered 25.17% and BLFS delivered 36.27% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ASTH analysis Full BLFS analysis Interactive comparison tool

Dig into the metrics

Astrana Health P/E ratio BioLife Solutions P/E ratio Astrana Health ROE BioLife Solutions ROE Astrana Health operating margin BioLife Solutions operating margin Astrana Health revenue growth BioLife Solutions revenue growth Astrana Health free cash flow BioLife Solutions free cash flow

Astrana Health & BioLife Solutions appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.